Purpose Life Sciences, Author at Purpose Life Sciences

Publications

Interferon treatments for SARS-CoV-2: Challenges and opportunities

Interferon (IFN) therapies are used to treat a variety of infections and diseases and could be used to treat SARS-CoV-2. However, optimal use and timing of IFN therapy to treat SARS-CoV-2 is not well documented. We aimed to synthesize available evidence to understand whether interferon therapy should be recommended for…

Purpose Life SciencesApril 21, 2022

Publications

Effect of early treatment with ivermectin among patients with COVID-19

The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear.

Purpose Life SciencesMarch 20, 2022

Publications

How COVID-19 has fundamentally changed clinical research in global health

The COVID-19 pandemic has put enormous pressure on the medical research community to move quickly, yet many clinical trials have been arguably inefficient with questionable methdological quality. The pandemic has highlighted the need for more collaboration and coordination, with large scale clinical trials and master protocols that can inform policy…

Purpose Life SciencesMay 1, 2021

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Purpose Life Sciences

Interferon treatments for SARS-CoV-2: Challenges and opportunities

Effect of early treatment with ivermectin among patients with COVID-19

How COVID-19 has fundamentally changed clinical research in global health

Cookie Policy